Skip to main content
Fig. 4 | BMC Infectious Diseases

Fig. 4

From: Trends and correlation between antibacterial consumption and carbapenem resistance in gram-negative bacteria in a tertiary hospital in China from 2012 to 2019

Fig. 4

Associations of antibiotic usage and carbapenem resistance rates in E. coli, A. baumannii, E. cloacae, and B. cepacia in the entire study period. a Correlation between usage of carbapenems and carbapenem resistance in E. coli. b Associations of usage of tetracyclines, carbapenems, and C/BLI combinations with carbapenem resistance in A. baumannii. c Associations of usage of carbapenems and P/BLI combinations with carbapenem resistance in E. cloacae. d Correlation between consumption of quinolones and carbapenem resistance in B. cepacia. C/BLI: cephalosporin/β-lactamase inhibitor; P/BLI: penicillin/β-Lactamase inhibitor. Consumption of antibiotic was expressed in defined daily doses (DDDs)/1000 patient-days

Back to article page